Balliet J W, Berson J, D'Cruz C M, Huang J, Crane J, Gilbert J M, Bates P
Department of Microbiology, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
J Virol. 1999 Apr;73(4):3054-61. doi: 10.1128/JVI.73.4.3054-3061.1999.
The receptor for the subgroup A avian sarcoma and leukosis viruses [ASLV(A)] is the cellular glycoprotein Tva. A soluble form of Tva, sTva, was produced and purified with a baculovirus expression system. Using this system, 7 to 10 mg of purified sTva per liter of cultured Sf9 cells was obtained. Characterization of the carbohydrate modification of sTva revealed that the three N glycosylation sites in sTva were differentially utilized; however, the O glycosylation common to Tva produced in mammalian and avian cells was not observed. Purified sTva demonstrates significant biological activity, specifically blocking infection of avian cells by ASLV(A) with a 90% inhibitory concentration of approximately 25 pM. A quantitative enzyme-linked immunosorbent assay, developed to assess the binding of sTva to ASLV envelope glycoprotein, demonstrates that sTva has a high affinity for EnvA, with an apparent dissociation constant of approximately 0.3 nM. Once they are bound, a very stable complex is formed between EnvA and sTva, with an estimated complex half-life of 6 h. The soluble receptor protein described here represents a valuable tool for analysis of the receptor-envelope glycoprotein interaction and for structural analysis of Tva.
A亚群禽肉瘤和白血病病毒(ASLV[A])的受体是细胞糖蛋白Tva。利用杆状病毒表达系统制备并纯化了Tva的可溶性形式sTva。使用该系统,每升培养的Sf9细胞可获得7至10毫克纯化的sTva。对sTva糖基化修饰的表征显示,sTva中的三个N糖基化位点被不同程度地利用;然而,未观察到在哺乳动物和禽类细胞中产生的Tva所共有的O糖基化。纯化的sTva表现出显著的生物学活性,具体表现为以约25 pM的90%抑制浓度阻断ASLV(A)对禽类细胞的感染。为评估sTva与ASLV包膜糖蛋白的结合而开发的定量酶联免疫吸附测定表明,sTva对EnvA具有高亲和力,表观解离常数约为0.3 nM。一旦它们结合,EnvA和sTva之间就会形成非常稳定的复合物,估计复合物半衰期为6小时。本文所述的可溶性受体蛋白是分析受体-包膜糖蛋白相互作用以及Tva结构分析的宝贵工具。